John Vavricka serves as Executive at Atea Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, John Vavricka has executed 3 insider transactions totaling $45.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 1, 2024 involved selling 11,819 shares valued at $45.4K.
John Vavricka currently holds 21,515 shares of Atea Pharmaceuticals, Inc. (AVIR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Vavricka has been a net seller of AVIR stock. They have purchased $0 and sold $45.4K worth of shares.
John Vavricka's most recent insider trade was on Feb 1, 2024, when they sold 11,819 shares at $3.84 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 3, 2020 | AVIR | $0 | Conversion | 82,508 | $N/A | Discretionary |